arjunolic acid has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manna, P; Sil, PC; Sinha, M | 1 |
| Manna, P; Sil, PC | 1 |
2 other study(ies) available for arjunolic acid and cytochrome c-t
| Article | Year |
|---|---|
Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Caspase 3; Cytochromes c; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Hypoglycemic Agents; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pancreas; Phosphorylation; Protein Carbonylation; Rats; Reactive Nitrogen Species; Reactive Oxygen Species; Time Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2009 |
Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: Protective role of arjunolic acid.
Topics: Animals; Antioxidants; Apoptosis; Chemokine CCL2; Cytochromes c; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Mitochondria; Mitochondrial Membranes; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction; Triterpenes; Vascular Endothelial Growth Factor A | 2012 |